Kapłon-Cieślicka, A;
Benson, L;
Chioncel, O;
Crespo-Leiro, MG;
Coats, AJS;
Anker, SD;
Ruschitzka, F;
Hage, C;
Drożdż, J;
Seferovic, P;
et al.
Kapłon-Cieślicka, A; Benson, L; Chioncel, O; Crespo-Leiro, MG; Coats, AJS; Anker, SD; Ruschitzka, F; Hage, C; Drożdż, J; Seferovic, P; Rosano, GMC; Piepoli, M; Mebazaa, A; McDonagh, T; Lainscak, M; Savarese, G; Ferrari, R; Mullens, W; Bayes-Genis, A; Maggioni, AP; Lund, LH; on behalf of the Heart Failure Association (HFA) of the European
(2023)
Hyponatraemia and changes in natraemia during hospitalization for acute heart failure and associations with in-hospital and long-term outcomes - from the ESC-HFA EORP Heart Failure Long-Term Registry.
Eur J Heart Fail, 25 (9).
pp. 1571-1583.
ISSN 1879-0844
https://doi.org/10.1002/ejhf.2873
SGUL Authors: Rosano, Giuseppe Massimo Claudio
|
PDF
Published Version
Available under License Creative Commons Attribution Non-commercial. Download (981kB) | Preview |
|
Archive (ZIP) (Appendix S1. Supporting Information)
Published Version
Available under License Creative Commons Attribution Non-commercial. Download (97kB) |
Abstract
AIMS: To comprehensively assess hyponatraemia in acute heart failure (AHF) regarding prevalence, associations, hospital course, and post-discharge outcomes. METHODS AND RESULTS: Of 8298 patients in the European Society of Cardiology Heart Failure Long-Term Registry hospitalized for AHF with any ejection fraction, 20% presented with hyponatraemia (serum sodium <135 mmol/L). Independent predictors included lower systolic blood pressure, estimated glomerular filtration rate (eGFR) and haemoglobin, along with diabetes, hepatic disease, use of thiazide diuretics, mineralocorticoid receptor antagonists, digoxin, higher doses of loop diuretics, and non-use of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers and beta-blockers. In-hospital death occurred in 3.3%. The prevalence of hyponatraemia and in-hospital mortality with different combinations were: 9% hyponatraemia both at admission and discharge (hyponatraemia Yes/Yes, in-hospital mortality 6.9%), 11% Yes/No (in-hospital mortality 4.9%), 8% No/Yes (in-hospital mortality 4.7%), and 72% No/No (in-hospital mortality 2.4%). Correction of hyponatraemia was associated with improvement in eGFR. In-hospital development of hyponatraemia was associated with greater diuretic use and worsening eGFR but also more effective decongestion. Among hospital survivors, 12-month mortality was 19% and adjusted hazard ratios (95% confidence intervals) were for hyponatraemia Yes/Yes 1.60 (1.35-1.89), Yes/No 1.35 (1.14-1.59), and No/Yes 1.18 (0.96-1.45). For death or heart failure hospitalization they were 1.38 (1.21-1.58), 1.17 (1.02-1.33), and 1.09 (0.93-1.27), respectively. CONCLUSION: Among patients with AHF, 20% had hyponatraemia at admission, which was associated with more advanced heart failure and normalized in half of patients during hospitalization. Admission hyponatraemia (possibly dilutional), especially if it did not resolve, was associated with worse in-hospital and post-discharge outcomes. Hyponatraemia developing during hospitalization (possibly depletional) was associated with lower risk.
Item Type: | Article | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Additional Information: | © 2023 The Authors. European Journal of Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Keywords: | Acute heart failure, Congestion, Hyponatraemia, Prognosis, Sodium, Worsening heart failure, Acute heart failure, Worsening heart failure, Hyponatraemia, Sodium, Prognosis, Congestion, 1102 Cardiorespiratory Medicine and Haematology, Cardiovascular System & Hematology | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
SGUL Research Institute / Research Centre: | Academic Structure > Molecular and Clinical Sciences Research Institute (MCS) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Journal or Publication Title: | Eur J Heart Fail | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ISSN: | 1879-0844 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Language: | eng | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Dates: |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Publisher License: | Creative Commons: Attribution-Noncommercial 4.0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Projects: |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
PubMed ID: | 37114294 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Web of Science ID: | WOS:000993762100001 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Go to PubMed abstract | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
URI: | https://openaccess.sgul.ac.uk/id/eprint/115535 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Publisher's version: | https://doi.org/10.1002/ejhf.2873 |
Statistics
Actions (login required)
Edit Item |